Te‐Chang Lee

5.9k total citations
143 papers, 4.5k citations indexed

About

Te‐Chang Lee is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Te‐Chang Lee has authored 143 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 25 papers in Oncology and 24 papers in Organic Chemistry. Recurrent topics in Te‐Chang Lee's work include Cancer therapeutics and mechanisms (23 papers), Retinoids in leukemia and cellular processes (18 papers) and Arsenic contamination and mitigation (17 papers). Te‐Chang Lee is often cited by papers focused on Cancer therapeutics and mechanisms (23 papers), Retinoids in leukemia and cellular processes (18 papers) and Arsenic contamination and mitigation (17 papers). Te‐Chang Lee collaborates with scholars based in Taiwan, United States and India. Te‐Chang Lee's co-authors include I‐Ching Ho, Ling‐Huei Yih, J. Carl Barrett, Hung‐Yi Chiou, Rajesh Kakadiya, Meei‐Maan Wu, Rong Huang, K.Y. Jan, Mitsuo Oshimura and Anamik Shah and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Te‐Chang Lee

139 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Te‐Chang Lee Taiwan 41 2.4k 1.0k 836 728 595 143 4.5k
Yeong‐Shiau Pu Taiwan 42 2.5k 1.0× 732 0.7× 840 1.0× 718 1.0× 183 0.3× 312 7.0k
Yunfeng Zhao China 41 1.9k 0.8× 1.1k 1.1× 634 0.8× 1.5k 2.1× 172 0.3× 137 4.5k
Christine F. Skibola United States 35 1.9k 0.8× 421 0.4× 560 0.7× 559 0.8× 115 0.2× 74 4.8k
Keiichirou Morimura Japan 30 1.7k 0.7× 330 0.3× 825 1.0× 413 0.6× 113 0.2× 95 3.5k
Bhalchandra A. Diwan United States 46 3.0k 1.2× 1.5k 1.4× 1.3k 1.6× 2.7k 3.8× 127 0.2× 172 7.3k
Olivier Fardel France 52 2.4k 1.0× 417 0.4× 635 0.8× 1.3k 1.8× 170 0.3× 214 8.3k
J. Christopher States United States 42 2.6k 1.1× 1.0k 1.0× 886 1.1× 1.0k 1.4× 62 0.1× 141 4.5k
Shoji Fukushima Japan 32 958 0.4× 208 0.2× 626 0.7× 610 0.8× 273 0.5× 212 3.6k
Samuel Waxman United States 50 7.8k 3.2× 558 0.5× 1.2k 1.4× 178 0.2× 309 0.5× 156 10.8k
Xianglin Shi United States 36 2.3k 0.9× 119 0.1× 670 0.8× 525 0.7× 160 0.3× 72 4.1k

Countries citing papers authored by Te‐Chang Lee

Since Specialization
Citations

This map shows the geographic impact of Te‐Chang Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Chang Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Chang Lee more than expected).

Fields of papers citing papers by Te‐Chang Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te‐Chang Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Chang Lee. The network helps show where Te‐Chang Lee may publish in the future.

Co-authorship network of co-authors of Te‐Chang Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Te‐Chang Lee. A scholar is included among the top collaborators of Te‐Chang Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te‐Chang Lee. Te‐Chang Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chung‐Ji, et al.. (2023). IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer. Biomedicines. 11(3). 896–896. 3 indexed citations
2.
Patel, Anil S., Vicky Jain, Yi‐Wen Lin, et al.. (2020). Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives. European Journal of Medicinal Chemistry. 202. 112516–112516. 13 indexed citations
3.
Hong, Shiao‐Ya, et al.. (2018). Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma. Cancer Research. 78(17). 4984–4996. 39 indexed citations
4.
Liao, Yi‐Chun, Yifan Chen, & Te‐Chang Lee. (2014). Increased susceptibility of H-Ras G12V -transformed human urothelial cells to the genotoxic effects of sodium arsenite. Archives of Toxicology. 89(11). 1971–1979. 7 indexed citations
5.
Chen, Hui-Chi, Chi‐Ling Chen, San‐Lin You, et al.. (2014). A Prospective Study of Gynecological Cancer Risk in Relation to Adiposity Factors: Cumulative Incidence and Association with Plasma Adipokine Levels. PLoS ONE. 9(8). e104630–e104630. 20 indexed citations
6.
Yen, Jiin‐Cherng, et al.. (2013). Determination of tissue distribution of potent antitumor agent ureidomustin (BO-1055) by HPLC and its pharmacokinetic application in rats. Journal of Chromatography B. 917-918. 62–70. 5 indexed citations
7.
Chen, Chi‐Wei, Pei‐Chih Lee, Rajesh Kakadiya, et al.. (2012). Synthesis and antitumor evaluation of novel Benzo[d]pyrrolo[2,1-b]thiazole derivatives. European Journal of Medicinal Chemistry. 53. 28–40. 34 indexed citations
8.
10.
Lin, Ya‐Ping, et al.. (2011). Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide‐induced mitotically arrested cells. PROTEOMICS. 11(22). 4331–4345. 17 indexed citations
11.
Wu, Meei‐Maan, Hung‐Yi Chiou, Chi‐Ling Chen, et al.. (2010). GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Toxicology and Applied Pharmacology. 248(3). 226–233. 28 indexed citations
12.
Chang, Kuo‐Wei, et al.. (2008). IFN-Induced Protein with Tetratricopeptide Repeats 2 Inhibits Migration Activity and Increases Survival of Oral Squamous Cell Carcinoma. Molecular Cancer Research. 6(9). 1431–1439. 44 indexed citations
13.
Chang, Kuo‐Wei, et al.. (2006). Enhanced expression of ASB6 and IFIT2 in oral squamous cell carcinoma. Cancer Research. 66. 215–215. 2 indexed citations
14.
Tsai, Chen‐An, Chun‐Houh Chen, Te‐Chang Lee, et al.. (2004). Gene Selection for Sample Classifications in Microarray Experiments. DNA and Cell Biology. 23(10). 607–614. 19 indexed citations
15.
Lin, Chijen R., Pan‐Chyr Yang, Ming‐Ta Hsu, et al.. (1998). Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-β1. Toxicology. 127(1-3). 157–166. 31 indexed citations
16.
Jagirdar, Jaishree, R. Bégin, A. Dufresne, et al.. (1996). Transforming Growth Factor-Beta (TGF-Beta) in Silicosis. American Journal of Respiratory and Critical Care Medicine. 154(4). 1076–1081. 83 indexed citations
17.
Aston, Christopher E., Jaishree Jagirdar, Te‐Chang Lee, et al.. (1995). Enhanced Insulin-Like Growth Factor Molecules in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 151(5). 1597–1603. 65 indexed citations
18.
Gurr, Jia-Ran, Ying‐Chun Lin, I‐Ching Ho, Kun-Yan Jan, & Te‐Chang Lee. (1993). Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during the G2 phase. Mutation Research/Genetic Toxicology. 319(2). 135–142. 36 indexed citations
19.
Lee, Te‐Chang, Jiunn‐Liang Ko, & K.Y. Jan. (1989). Differential cytotoxicity of sodium arsenite in human fibroblasts and Chinese hamster ovary cells. Toxicology. 56(3). 289–299. 58 indexed citations
20.
Lin, Ying‐Chun, I‐Ching Ho, & Te‐Chang Lee. (1989). Ethanol and acetaldehyde potentiate the clastogenicity of ultraviolet light, methyl methanesulfonate, mitomycin C and bleomycin in Chinese hamster ovary cells. Mutation Research/Environmental Mutagenesis and Related Subjects. 216(2). 93–99. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026